ArticleScientific reports2025
Comparison of Niosomal formulation of citrus limon peel extracts and doxorubicin effects on MCF-7 and MDA-MB-231 human breast cancer cells.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Niosome represents a practical approach for targeted the in vitro delivery of phytochemicals and drugs to cells. also it is a promising delivery system for plant extracts and reduces the side effects of burst release of doxorubicin. Ethanolic lemon peel extract (EE), methanolic extract (ME), and doxorubicin (DOXO) were formulated into ethanolic, methanolic, and doxorubicin niosomal formulations, denoted as NIO/EE, NIO/ME, and NIO/DOXO, respectively. These formulations were applied to MCF-7 and MDA-MB-231 breast cancer cell lines for a duration of 48 h. The cells' apoptosis/necrosis and migration rates were measured using Annexin V/PI staining and wound healing assays. Gene expression was measured by qPCR. The results show that NIO/EE and NIO/ME treatments notably elevated the apoptosis rate to unformulated extracts (P < 0.0001). However, NIO/DOXO has significantly milder cytotoxicity than DOXO. The extracts significantly inhibited the migration of both cell lines (P < 0.0001). An increase in FAS expression (****P < 0.0001) and a decreased expression level of VIMENTIN, SNAIL, and JNK-2 genes (***P < 0.001, ****P < 0.0001) is shown in all two cell lines treated with niosomal formulation containing NIO/EE and NIO/ME that confirmed apoptosis induction and migration inhibition by encapsulated extracts. The study aims to evaluate the enhanced anticancer activity usefulness of noisome-encapsulating lemon peel extracts and doxorubicin on breast cancer cells. Further research will reveal the in vivo effects of the extracts in animal models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.